The Inflation Reduction Act: The Impact of Medicare Negotiation of Prescription Drug Prices on Hospitals and Health Systems
Omnicell
JANUARY 10, 2023
Ken Perez Vice President of Healthcare Policy and Government Affairs, Omnicell In August, H.R. Since the drugs that would be negotiation-eligible for implementation in 2026 are unknown, and the prices that will be dictated by Medicare have not been set, modeling of the impact on the 340B Program is not feasible. ” Sen.
52 
Let's personalize your content